Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
For people with eating disorders, the COVID pandemic is creating an array of new challenges that can disrupt coping strategies and pose a risk to recovery.
Googling for financial issues and disaster help rose sharply early in the COVID-19 pandemic and may portend a future increase in suicides, Columbia researchers found.
Madelyn Gould’s research into the effectiveness of suicide hotlines helped pave the way for 988, a new nationwide suicide hotline number that will become operational in 2022.
Multiple neurons in the brain must fire in synchrony to create persistent memories tied to intense emotions, new research from Columbia neuroscientists has found.
With high precision, a new algorithm predicts which patients treated for traumatic injuries in the emergency department will later develop post-traumatic stress disorder.
During the height of the COVID-19 pandemic in New York City, health care workers on the front lines had high levels of acute stress, anxiety, and depression.
Primary care providers have expanded access to buprenorphine for adults, but use of the opioid addiction treatment has decreased among the youngest patients, Columbia researchers have found.
CopeColumbia provides faculty and staff with support services and guidance for stress management, psychological support, and emotional fatigue arising from the COVID-19 pandemic.